Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Chronic Heart Failure

Free Subscription Articles published in J Thorac Cardiovasc Surg Retrieve available abstracts of 71 articles: HTML format

Single Articles

November 2025
1. BURCHILL LJ
   Commentary: The 60-Year Legacy of Fontan: Redefining Survival And Future Possibilities in Heart Failure.
   J Thorac Cardiovasc Surg. 2025 Nov 11:S0022-5223(25)00973.
   PubMed    
   
   
   October 2025
2. CATALANO MA, Edelson JB, Toubat O, Beqaj H, et al
   Contemporary outcomes and healthcare costs associated with single-ventricle heart failure admissions in adults in the United States.
   J Thorac Cardiovasc Surg. 2025 Oct 13:S0022-5223(25)00872.
   PubMed     Abstract available
   
   
   June 2025
3. OHMORI T, Hiraoka A, Hamada Y, Kishimoto S, et al
   Long-term Prognostic Value of HFA-PEFF Score in Patients Undergoing Isolated Surgical Aortic Valve Replacement for Severe Aortic Stenosis.
   J Thorac Cardiovasc Surg. 2025 Jun 25:S0022-5223(25)00541.
   PubMed     Abstract available
   
   
   
4. PEGUES J, Danesh S, Cascino TM, Cowger JA, et al
   Impact of Post-Implant Mitral Regurgitation on Durable Left Ventricular Assist Device Outcomes.
   J Thorac Cardiovasc Surg. 2025 Jun 24:S0022-5223(25)00539.
   PubMed     Abstract available
   
   
   
5. OVERBEY DM, Kucera JA, Aykut B, Wolf SE, et al
   Pediatric Heart Transplant in Donation After Circulatory Death using Normothermic Regional Perfusion.
   J Thorac Cardiovasc Surg. 2025 Jun 20:S0022-5223(25)00535.
   PubMed     Abstract available
   
   
   April 2025
6. DAVIES RR, Iqbal M, Lantz-Thomason J, Carrington S, et al
   Paracorporeal continuous flow ventricular assist devices (cfvads) for children < 20 kg: Challenging the paradigm in the smallest patients.
   J Thorac Cardiovasc Surg. 2025 Apr 29:S0022-5223(25)00323.
   PubMed     Abstract available
   
   
   
7. MULLIS DM, Garrison A, Heng E, Zhu Y, et al
   Heart-liver transplantation using the en bloc technique: A single-center experience over two decades.
   J Thorac Cardiovasc Surg. 2025;169:1254-1262.
   PubMed     Abstract available
   
   
   February 2025
8. REBOLLEDO MA, Knott-Craig CJ, Corson AH, Phillip R, et al
   Right Ventricular Endomyocardial Fibrosis with an Unguarded Tricuspid Valve - Surgical Management of a 9-year-old with Severe Right Heart Failure.
   J Thorac Cardiovasc Surg. 2025 Feb 4:S0022-5223(25)00096.
   PubMed    
   
   
   
9. MOELLER CM, Rubinstein G, Oren D, Valledor AF, et al
   Validation of the HeartMate 3 survival risk score in a large left ventricular assist device center.
   J Thorac Cardiovasc Surg. 2025;169:650-657.
   PubMed     Abstract available
   
   
   September 2024
10. NORDAN T, Keshk M, Hackmann A, Givertz MM, et al
    The Impact of Blood Type and Body Size on Successful Bridging to Heart Transplantation using Intraaortic Balloon Pump or Surgically Implanted Microaxial Left Ventricular Assist Device.
    J Thorac Cardiovasc Surg. 2024 Sep 25:S0022-5223(24)00835.
    PubMed     Abstract available
    
    
    
11. PLA MM, Russell SD, Milano CA, Chiang Y, et al
    Late Follow-up for a Randomized Trial of Surgical Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation.
    J Thorac Cardiovasc Surg. 2024 Sep 21:S0022-5223(24)00830.
    PubMed     Abstract available
    
    
    
12. MOROI MK, Patel K, Rajesh K, Lin A, et al
    Early Outcomes in Heart Transplantation using Donation after Circulatory Death Donors in Patients Bridged with Durable Left Ventricular Assist Devices.
    J Thorac Cardiovasc Surg. 2024 Sep 9:S0022-5223(24)00788.
    PubMed     Abstract available
    
    
    
13. BRLECIC PE, Ghanta RK
    Commentary: Building bridges to recovery in patients with ventricular assist devices.
    J Thorac Cardiovasc Surg. 2024;168:e89-e90.
    PubMed    
    
    
    
14. HEIMA D, Takeda M, Tabata Y, Minatoya K, et al
    Therapeutic potential of human induced pluripotent stem cell-derived cardiac tissue in an ischemic model with unloaded condition mimicking left ventricular assist device.
    J Thorac Cardiovasc Surg. 2024;168:e72-e88.
    PubMed     Abstract available
    
    
    August 2024
15. 
    Discussion to: Outcome of patients supported with HeartMate 3 after extracorporeal life support: On behlaf of the Durable Mechanical Circulatory Support After Extracorporeal Life Support Study Group.
    J Thorac Cardiovasc Surg. 2024;168:579-580.
    PubMed    
    
    
    July 2024
16. 
    Discussion to: Preoperative passive venous pressure-driven cardiac function determines left ventricular assist device outcomes.
    J Thorac Cardiovasc Surg. 2024;168:145-146.
    PubMed    
    
    
    
17. TANG PC, Millar J, Noly PE, Sicim H, et al
    Preoperative passive venous pressure-driven cardiac function determines left ventricular assist device outcomes.
    J Thorac Cardiovasc Surg. 2024;168:133-144.
    PubMed     Abstract available
    
    
    June 2024
18. NGUYEN A, Schaff HV
    Is Transplantation the Only Option for Diastolic Heart Failure?
    J Thorac Cardiovasc Surg. 2024 Jun 13:S0022-5223(24)00525.
    PubMed    
    
    
    
19. GUZMAN-GOMEZ A, Greenberg JW, Dani A, Villa C, et al
    In the era of outpatient ventricular assist devices, is it time to reconsider the practice of bridging older children to transplant on outpatient inotropes?
    J Thorac Cardiovasc Surg. 2024;167:2206-2214.
    PubMed     Abstract available
    
    
    
20. MOVAHEDI F, Pagani FD, Antaki JF
    In search of similarity in adverse events journeys of patients with left ventricular assist devices.
    J Thorac Cardiovasc Surg. 2024;167:2147-2156.
    PubMed     Abstract available
    
    
    May 2024
21. HYNDS MA, Hayashi H, Kurlansky P, Zhao Y, et al
    Medium-Term Outcomes of Concomitant Aortic Valve Repair in Patients with Continuous-Flow Left Ventricular Assist Device.
    J Thorac Cardiovasc Surg. 2024 May 25:S0022-5223(24)00447.
    PubMed     Abstract available
    
    
    
22. 
    Discussion to: Modifiable risk factor reduction for pediatric ventricular assist devices and the influence of persistent modifiable risk factors at transplant.
    J Thorac Cardiovasc Surg. 2024;167:1564-1565.
    PubMed    
    
    
    
23. GREENBERG JW, Kulshrestha K, Guzman-Gomez A, Fields K, et al
    Modifiable risk factor reduction for pediatric ventricular assist devices and the influence of persistent modifiable risk factors at transplant.
    J Thorac Cardiovasc Surg. 2024;167:1556-1563.
    PubMed     Abstract available
    
    
    
24. KONSTANTINOV IE, Davies B
    Durable ventricular assist device implantation in a child after double switch operation.
    J Thorac Cardiovasc Surg. 2024;167:1566-1569.
    PubMed    
    
    
    
25. SILVESTRY SC
    Commentary: Tricuspid repair and left ventricular assist device: A new baseline.
    J Thorac Cardiovasc Surg. 2024;167:1821-1822.
    PubMed    
    
    
    
26. SIMPSON MT, Ning Y, Kurlansky P, Colombo PC, et al
    Outcomes of treatment for deep left ventricular assist device infection.
    J Thorac Cardiovasc Surg. 2024;167:1824-1832.
    PubMed     Abstract available
    
    
    April 2024
27. SAKURAI Y, Mehaffey JH, Kuno T, Yokoyama Y, et al
    The impact of permanent pacemaker implantation on long-term survival following cardiac surgery; A systematic review and meta-analysis.
    J Thorac Cardiovasc Surg. 2024 Apr 22:S0022-5223(24)00368.
    PubMed     Abstract available
    
    
    
28. BLEIWEIS MS, Philip J, Peek GJ, Jacobs JP, et al
    Commentary: Challenges associated with long-term implantable ventricular assist device support in children.
    J Thorac Cardiovasc Surg. 2024;167:1429-1430.
    PubMed    
    
    
    
29. WERT L, Stewart GC, Mehra MR, Milwidsky A, et al
    A multicenter evaluation of external outflow graft obstruction with a fully magnetically levitated left ventricular assist device.
    J Thorac Cardiovasc Surg. 2024;167:1322-1330.
    PubMed     Abstract available
    
    
    March 2024
30. ALNSASRA H, Perue RK, Khalil F, Regev O, et al
    Reversibility of Precapillary Pulmonary Hypertension and Outcomes After Heart Transplantation Bridged with Left Ventricular Assist Devices: Insight from the UNOS.
    J Thorac Cardiovasc Surg. 2024 Mar 5:S0022-5223(24)00188.
    PubMed     Abstract available
    
    
    
31. AZIZGOLSHANI N, Takeda K
    Commentary: What is the destination after left ventricular assist device under the new heart allocation system?
    J Thorac Cardiovasc Surg. 2024;167:1060-1061.
    PubMed    
    
    
    February 2024
32. GOSEV I, Pham DT, Um JY, Anyanwu AC, et al
    Ventricular Assist Device using a Thoracotomybased Implant Technique: Multi-center HeartMate 3 SWIFT Study.
    J Thorac Cardiovasc Surg. 2024 Feb 15:S0022-5223(24)00179.
    PubMed     Abstract available
    
    
    
33. SINGH SK, Hassanein M, Ning Y, Wang C, et al
    Increasing waiting times for status 2 patients in new United Network for Organ Sharing allocation system: Impact on waitlist and posttransplant outcomes.
    J Thorac Cardiovasc Surg. 2024;167:535-543.
    PubMed     Abstract available
    
    
    
34. VINOGRADSKY A, Ning Y, Kurlansky P, Kirschner M, et al
    Less is better? Comparing effects of median sternotomy and thoracotomy surgical approaches for left ventricular assist device implantation on postoperative outcomes and valvulopathy.
    J Thorac Cardiovasc Surg. 2024;167:731-743.
    PubMed     Abstract available
    
    
    
35. DIMAGLI A, Worku B, Gaudino M
    Commentary: Minimally invasive left ventricular assist device implantation: Did we forget the valve?
    J Thorac Cardiovasc Surg. 2024;167:744-745.
    PubMed    
    
    
    January 2024
36. ITAGAKI S, Toyoda N, Egorova N, Sun E, et al
    Total artificial heart implantation as a bridge to transplantation in the United States.
    J Thorac Cardiovasc Surg. 2024;167:205-214.
    PubMed     Abstract available
    
    
    December 2023
37. KIRSCHNER M, Topkara VK, Sun J, Kurlansky P, et al
    Comparing 3-Year Survival and Readmissions between HeartMate 3 and Heart Transplant as Primary Treatment for Advanced Heart Failure.
    J Thorac Cardiovasc Surg. 2023 Dec 26:S0022-5223(23)01207.
    PubMed     Abstract available
    
    
    
38. 
    Discussion to: Simultaneous heart-kidney transplant compared with heart transplant alone in patients with borderline renal function who are not dialysis dependent.
    J Thorac Cardiovasc Surg. 2023 Dec 2:S0022-5223(23)01088.
    PubMed    
    
    
    
39. TUME SC, Fuentes-Baldemar AA, Anders M, Spinner JA, et al
    Temporary ventricular assist device support with a catheter-based axial pump: Changing the paradigm at a pediatric heart center.
    J Thorac Cardiovasc Surg. 2023;166:1756-1763.
    PubMed     Abstract available
    
    
    
40. JOHN R, Kanwar MK, Cleveland JC Jr, Uriel N, et al
    Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial
    J Thorac Cardiovasc Surg. 2023;166:1684-1694.
    PubMed     Abstract available
    
    
    October 2023
41. CHO J, Tunuguntla HP, Tume SC, Spinner JA, et al
    Long-term Implantable Ventricular Assist Device Support in Children.
    J Thorac Cardiovasc Surg. 2023 Oct 30:S0022-5223(23)01005.
    PubMed     Abstract available
    
    
    
42. DECAMPLI WM
    Commentary: Is machine learning needed to understand that heart failure is a risk in adult congenital cardiac surgery?
    J Thorac Cardiovasc Surg. 2023 Oct 14:S0022-5223(23)00977.
    PubMed    
    
    
    
43. FENG I, Wang AS, Takeda K, Topkara VK, et al
    Simultaneous Heart-Kidney Transplant Compared to Heart Transplant Alone in Non-Dialysis Dependent Patients with Borderline Renal Function.
    J Thorac Cardiovasc Surg. 2023 Oct 12:S0022-5223(23)00960.
    PubMed     Abstract available
    
    
    
44. KONSTANTINOV IE, Brizard CP, Davies B
    Severe aortic valve insufficiency in infants on durable ventricular assist device support.
    J Thorac Cardiovasc Surg. 2023 Oct 12:S0022-5223(23)00914.
    PubMed    
    
    
    
45. SCHUELER S, Bowles CT, Hinkel R, Wohlfarth R, et al
    A novel intrapericardial pulsatile device for individualized, biventricular circulatory support without direct blood contact.
    J Thorac Cardiovasc Surg. 2023;166:1119-1129.
    PubMed     Abstract available
    
    
    
46. MOAZAMI N, Smith D
    Commentary: Direct cardiac compression device for biventricular support: If we put lipstick on a pig, is it still a pig?
    J Thorac Cardiovasc Surg. 2023;166:1130-1131.
    PubMed    
    
    
    September 2023
47. GRIFFETH EM, Stephens EH, Dearani JA, Shreve JT, et al
    Impact of Heart Failure on Reoperation in Adult Congenital Heart Disease: An Innovative Machine Learning Model.
    J Thorac Cardiovasc Surg. 2023 Sep 28:S0022-5223(23)00871.
    PubMed     Abstract available
    
    
    
48. SAEED D, Stark C, Otto W, Loforte A, et al
    Outcome of Patients supported with HeartMate 3 after Extra-corporeal Life Support. On behalf of Durable MCS after ECLS Study Group.
    J Thorac Cardiovasc Surg. 2023 Sep 7:S0022-5223(23)00763.
    PubMed     Abstract available
    
    
    August 2023
49. KING CL, Onohara D, Tom SK, Silverman M, et al
    Transapical Ventricular Reshaping Reduces Functional Mitral Regurgitation and Improves Ventricular Function in a Preclinical Model of Ischemic Cardiomyopathy.
    J Thorac Cardiovasc Surg. 2023 Aug 17:S0022-5223(23)00724.
    PubMed     Abstract available
    
    
    
50. ZHOU S, Yang G, Zhang M, Pienta M, et al
    Mortality following durable left ventricular assist device implantation by timing and type of first infection.
    J Thorac Cardiovasc Surg. 2023;166:570-579.
    PubMed     Abstract available
    
    
    July 2023
51. MONGE MC, Joong A
    Commentary: Bridging the gap with temporary ventricular assist devices in pediatrics.
    J Thorac Cardiovasc Surg. 2023;166:212-213.
    PubMed    
    
    
    June 2023
52. KULSHRESTHA K, Greenberg JW, Kennedy JT 3rd, Hogue S, et al
    National Experience with Pediatric Surgical Aortic Valve Repair - A Pediatric Health Information System Analysis.
    J Thorac Cardiovasc Surg. 2023 Jun 27:S0022-5223(23)00538.
    PubMed     Abstract available
    
    
    
53. MALAS J, Chen Q, Emerson D, Gill G, et al
    Socioeconomic Disparities in Mid-Term Outcomes After Repair for Degenerative Mitral Regurgitation.
    J Thorac Cardiovasc Surg. 2023 Jun 27:S0022-5223(23)00534.
    PubMed     Abstract available
    
    
    
54. LIU R, Li S, Yan J, Yan F, et al
    Fate of Transposition of the Great Arteries with Pulmonary Stenosis After Double-Root Translocation, Rastelli, and Reparation a l'Etage Ventriculaire.
    J Thorac Cardiovasc Surg. 2023 Jun 7:S0022-5223(23)00455.
    PubMed     Abstract available
    
    
    
55. PIENTA MJ, Noly PE, Janda AM, Tang PC, et al
    Rescuing the right ventricle: A conceptual framework to target new interventions for patients receiving a durable left ventricular assist device.
    J Thorac Cardiovasc Surg. 2023;165:2126-2131.
    PubMed    
    
    
    
56. ELDE S, He H, Lingala B, Baiocchi M, et al
    Analysis of the revised heart allocation policy and the influence of increased mechanical circulatory support on survival.
    J Thorac Cardiovasc Surg. 2023;165:2090-2103.
    PubMed     Abstract available
    
    
    
57. KILCOYNE MF, Blanding WM, Kilic A
    Commentary: Left ventricular assist device implantation and failure to rescue: New insights and familiar challenges.
    J Thorac Cardiovasc Surg. 2023;165:2124-2125.
    PubMed    
    
    
    April 2023
58. MOVAHEDI F, Padman R, Antaki JF
    Limitations of receiver operating characteristic curve on imbalanced data: Assist device mortality risk scores.
    J Thorac Cardiovasc Surg. 2023;165:1433-1442.
    PubMed     Abstract available
    
    
    March 2023
59. MANCINI D, Moss N
    Commentary: Bringing objectivity to the nonmedical evaluation of left ventricular assist device candidates.
    J Thorac Cardiovasc Surg. 2023;165:1123-1124.
    PubMed    
    
    
    
60. YOUNG BAC, Tang PC
    Commentary: How to predict a harmonious relationship between patients and their left ventricular assist device?
    J Thorac Cardiovasc Surg. 2023;165:1125-1126.
    PubMed    
    
    
    
61. OLT CK, Thuita LW, Soltesz EG, Tong MZ, et al
    Value of psychosocial evaluation for left ventricular assist device candidates.
    J Thorac Cardiovasc Surg. 2023;165:1111-1121.
    PubMed     Abstract available
    
    
    
62. ROBERTSON G, Baran DA, Copeland H
    Commentary: In search of the "good candidate" for mechanical circulatory support.
    J Thorac Cardiovasc Surg. 2023;165:1122-1123.
    PubMed    
    
    
    January 2023
63. PAGANI FD
    Commentary: Lack of benefit of tricuspid valve intervention with left ventricular assist device implantation? It's all in the details.
    J Thorac Cardiovasc Surg. 2023 Jan 21:S0022-5223(23)00084.
    PubMed    
    
    
    November 2022
64. MENDIOLA PLA M, Chiang Y, Nicoara A, Poehlein E, et al
    Surgical Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation: Interim analysis of the TVVAD trial.
    J Thorac Cardiovasc Surg. 2022 Nov 16:S0022-5223(22)01243.
    PubMed     Abstract available
    
    
    
65. CHO J, Fuentes-Baldemar AA, Tunuguntla HP, Spinner JA, et al
    Outcomes of temporary ventricular assist device: A pediatric institutional experience over 25 years.
    J Thorac Cardiovasc Surg. 2022 Nov 4:S0022-5223(22)01164.
    PubMed     Abstract available
    
    
    
66. SILVESTRY SC
    Commentary: Left ventricular assist device complications after heart transplantation: Then and now.
    J Thorac Cardiovasc Surg. 2022 Nov 4:S0022-5223(22)01173.
    PubMed    
    
    
    August 2022
67. EAPEN S, Nordan T, Critsinelis AC, Li B, et al
    Blood type O heart transplant candidates have longer waitlist time and higher delisting under the new allocation system.
    J Thorac Cardiovasc Surg. 2022 Aug 8. pii: S0022-5223(22)00826.
    PubMed     Abstract available
    
    
    February 2022
68. KIM HR, Kim WK, Kim JK, Kim HJ, et al
    Prognostic impact of the E/e' ratio in patients with chronic severe aortic regurgitation undergoing aortic valve replacement.
    J Thorac Cardiovasc Surg. 2022 Feb 2. pii: S0022-5223(22)00114.
    PubMed     Abstract available
    
    
    
69. BIANCO V, Kilic A, Yousef S, Serna-Gallegos D, et al
    The long-term impact of postoperative atrial fibrillation after cardiac surgery.
    J Thorac Cardiovasc Surg. 2022 Feb 1. pii: S0022-5223(22)00103.
    PubMed     Abstract available
    
    
    September 2021
70. BRAHMBHATT DH, Rao V
    Commentary: Bridge to bridge: No longer a bridge too far for successful cardiac transplant.
    J Thorac Cardiovasc Surg. 2021 Sep 29. pii: S0022-5223(21)01393.
    PubMed    
    
    
    
71. DUGGAL NM, Lei I, Wu X, Aaronson KD, et al
    Mitral regurgitation severity at left ventricular assist device implantation is associated with distinct myocardial transcriptomic signatures.
    J Thorac Cardiovasc Surg. 2021 Sep 14. pii: S0022-5223(21)01262.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.